Indian drugmakers look beyond generics as Sun Pharma buys Organon
--------------------------------------------------------------------
Source: Nikkei Asia
Published: 2026-04-27 18:23 UTC+10:00
Section: General
Factuality Score: 100
Opinion Category: Neutral
Topics: India, Business & Economy, Asia Pacific
--------------------------------------------------------------------
Snippet:
India's Sun Pharma is buying U.S.-based Organon for $11.75 billion in what is the largest overseas acquisition by a drugmaker from the South Asian country. © Reuters
--------------------------------------------------------------------